Cointime

Sonoma Pharmaceuticals

company

About

Sonoma Pharmaceuticals develops and markets a global array of treatments for dermatological conditions and advanced tissue care.

  • 51 - 100

Highlights

Total Funding Amount
$70M
Funding Rounds
1
Investors
3

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$70M
Industries
Health Care
Founded date
Jan 1, 1999
Number Of Employee
51 - 100
Operating Status
Active

Sonoma Pharmaceuticals is a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 33 countries. The company’s products, over 100 SKUs commercialized worldwide, are used to treat patients in advanced wound management, dermatology, women’s health and animal health; addressing the unmet medical needs of these markets—while raising the standard of patient care and lowering overall healthcare costs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$70M
Sonoma Pharmaceuticals has raised a total of $70M in funding over 2 rounds. Their latest funding was raised on Sep 30, 2020 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 30, 2020 Post-IPO Equity $70M 3 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
3
Sonoma Pharmaceuticals is funded by 3 investors. Lyell Immunopharma and ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Lyell Immunopharma — Post-IPO Equity
ARCH Venture Partners — Post-IPO Equity
Lilly Asia Ventures — Post-IPO Equity
Cointime
İçerikler
Şirket.